Synergistic Anticancer Effects of Cannabis sativa L. (Narlı variety) Seed Oil Combined with Doxorubicin through Modulation of Apoptosis in SH-SY5Y Neuroblastoma Cells
DOI:
https://doi.org/10.66588/NCMR.3.sp1.5Keywords:
Cannabis sativa L., Seed oil, Doxorubicin, SH-SY5Y, ApoptosisAbstract
This study aimed to investigate the synergistic and additive anticancer effects of Cannabis sativa L. (Narlı variety) seed oil (CSSO) in combination with doxorubicin (DOX) on SH-SY5Y human neuroblastoma cells, with a particular emphasis on apoptosis.
Cell viability was evaluated using the MTT assay to determine the IC50 values of CSSO and DOX. Drug combination effects were analyzed using the SynergyFinder platform, and the most favorable synergistic combination was evaluated using reverse transcription-quantitative PCR (RT-qPCR) to assess the expression of apoptosis-related genes.
SH-SY5Y cells were treated with CSSO (1–800 µg/mL) and DOX (1–50 µg/mL) for 24 h. The IC50 values were determined to be 96.84 µg/mL for CSSO and 1.84 µg/mL for DOX, respectively. SynergyFinder analysis revealed synergistic interactions at various concentrations. Among all tested combinations, 0.92 µg/mL DOX in combination with 48.42 µg/mL CSSO showed the most favorable synergistic interaction (CI = 0.88) and was selected for further analyses. At this concentration, the corresponding ZIP synergy score was 5.1, with a 54% growth inhibition. Furthermore, this combination significantly increased the mRNA expression of Caspase-3 and Bax to 1.28 ± 0.05-fold and 1.19 ± 0.11-fold of the DOX group, respectively, corresponding to 28% and 19% increases, respectively, while reducing Bcl-2 mRNA expression to 0.68 ± 0.07-fold of the DOX group (32% reduction) (p < 0.05).
These findings suggest that CSSO may enhance the anticancer activity of DOX by inducing apoptosis, indicating its potential as an experimental adjuvant strategy for combination therapy in neuroblastoma.
Downloads
References
Colon NC, Chung DH. Neuroblastoma. Adv Pediatr. 2011;58:297-311. https://doi.org/10.1016/j.yapd.2011.03.011
Kciuk M, Gielecińska A, Mujwar S, Kołat D, Kałuzińska-Kołat Ż, Celik I, et al. Doxorubicin—an agent with multiple mechanisms of anticancer activity. Cells. 2023;12(4):659. https://doi.org/10.3390/cells12040659
Kamińska K, Cudnoch-Jędrzejewska A. A review on the neurotoxic effects of doxorubicin. Neurotox Res. 2023;41(5):383-397. https://doi.org/10.1007/s12640-023-00652-5
Wongsawatkul O, Buachan P, Jaisin Y, Busarakumtragul P, Chainakul S, Watanapokasin R, et al. Effects of barakol from Cassia siamea on neuroblastoma SH-SY5Y cell line: A potential combined therapy with doxorubicin. Heliyon. 2024;10(3):e24694. https://doi.org/10.1016/j.heliyon.2024.e24694
Onoja JO, Mikled P, Betow JY, Chavasiri W. Synergistic in vitro anticancer activity of doxorubicin-betulinic acid against neuroblastoma (SH-SY5Y) and lung carcinoma (A549) supported by in silico targeting of ALK. Sci Afr. 2026;31:e03285. https://doi.org/10.1016/j.sciaf.2026.e03285
Ünlü I, Tuncer MC, Özdemir I. Exploring apoptotic pathways in SH-SY5Y neuroblastoma cells: combined effects of napabucasin and doxorubicin. Folia Morphol (Warsz). 2025;84(3):544-552. https://doi.org/10.5603/fm.103887
İnal S, İnal KS, Benli FM, Gökmen S, Şentürk B, Kasap P, et al. In vivo and in silico wound healing potential of Cannabis sativa seed oil through inflammation mediators. BMC Complement Med Ther. 2026;9. https://doi.org/10.1186/s12906-026-05462-8
Christodoulou MC, Rodosthenous P, Neophytou CM. Unveiling the antioxidant role of hemp oils in cancer prevention and treatment. Cancers (Basel). 2025;25:17(13):2128. https://doi.org/10.3390/cancers17132128
Yaman Z, Aydemir S, Ugur Y, Demirtaş S, Şentürk H, Şalva E, et al. Cytotoxic and pro‐apoptotic effects of cold‐pressed hemp seed oil on lung cells: Cannabinoid and fatty acid profiling via LC–MS/MS and GC–FID. Chemistry Select. 2025;10(46):e04822. https://doi.org/10.1002/slct.202504822
Balpınar Ö, Ertuğrul MS, Ayan AK, Tik B. Effect of native hemp seed oil enriched with cannabidiol on epigenetic stability and oxidative stress status of colon cancer cells. Clin Exp Health Sci. 2025;15(4): 962-967. https://doi.org/10.33808/clinexphealthsci.1545679
Lim JS, Im JH, Fu X, Kim MH, Seong YS, Lee JY, et al. Synergistic anticancer effects of fermented noni extract combined with 5-Fluorouracil, doxorubicin, and vincristine on A549, MCF-7, and SH-SY5Y cell models. Curr Issues Mol Biol. 2025;47(12):993. https://doi.org/10.3390/cimb47120993
Zhou X, Wang X, Li N, Guo Y, Yang X, Lei Y. Therapy resistance in neuroblastoma: Mechanisms and reversal strategies. Front Pharmacol. 2023;14:1114295. https://doi.org/10.3389/fphar.2023.1114295
Ianevski A, Giri AK, Aittokallio T. SynergyFinder 2.0: visual analytics of multi-drug combination synergies. Nucleic Acids Res. 2020;48(W1):488-493. https://doi.org/10.1093/nar/gkaa216
Cinar I, Yayla M, Tavaci T, Toktay E, Ugan RA, Bayram P, Halici H. In vivo and in vitro cardioprotective effect of gossypin against isoproterenol-induced myocardial infarction injury. Cardiovasc Toxicol. 2022;22(1):52-62. https://doi.org/10.1007/s12012-021-09698-3
Jones IC, Dass CR. Doxorubicin-induced cardiotoxicity: causative factors and possible interventions. J Pharm Pharmacol. 2022;74(12):1677-1688. https://doi.org/10.1093/jpp/rgac063.
Melo ESA, Asevedo EA, Duarte-Almeida JM, Nurkolis F, Syahputra RA, Park MN, et al. Mechanisms of cell death induced by cannabidiol against tumor cells: A review of preclinical studies. Plants (Basel). 2025;14(4):585. https://doi.org/10.3390/plants14040585
Özerkan D. The determination of cisplatin and luteolin synergistic effect on colorectal cancer cell apoptosis and mitochondrial dysfunction by fluorescence labelling. J Fluoresc. 2023; 33(3): 1217-1225. https://doi.org/10.1007/s10895-023-03145-y
Wong RS. Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res. 2011;30(1):87. https://doi.org/10.1186/1756-9966-30-87
Putri GFT. Bax/Bcl-2 ratio as the golden marker of apoptosis: molecular mechanisms and regulatory pathways. International Journal of Cell and Biomedical Science, 2025;4(10):309-317. https://doi.org/10.59278/cbs.v4i10.65
Synowiec E, Hoser G, Bialkowska-Warzecha J, Pawlowska E, Skorski T, Blasiak J. doxorubicin differentially induces apoptosis, expression of mitochondrial apoptosis-related genes, and mitochondrial potential in bcr-abl1-expressing cells sensitive and resistant to imatinib. Biomed Res Int. 2015;2015:673512. https://doi.org/10.1155/2015/673512
Downloads
Published
Issue
Section
Categories
How to Cite
